The beneficial effect of synbiotics consumption on Alzheimer's disease mouse model via reducing local and systemic inflammation
Alzheimer's disease (AD) is a neurodegenerative disease that impairs multiple memory domains without an effective prevention or treatment approach. Amyloid plaque‐induced neuroinflammation exacerbates neurodegeneration and cognitive impairment in AD. To reduce neuroinflammation, we applied preb...
Gespeichert in:
Veröffentlicht in: | IUBMB life 2022-08, Vol.74 (8), p.748-753 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 753 |
---|---|
container_issue | 8 |
container_start_page | 748 |
container_title | IUBMB life |
container_volume | 74 |
creator | Deng, Shin‐Meng Chen, Chia‐Jung Lin, Hung‐Lung Cheng, Irene H. |
description | Alzheimer's disease (AD) is a neurodegenerative disease that impairs multiple memory domains without an effective prevention or treatment approach. Amyloid plaque‐induced neuroinflammation exacerbates neurodegeneration and cognitive impairment in AD. To reduce neuroinflammation, we applied prebiotics or synbiotics to modulate the gut–brain axis in the AD mouse model. AD‐like deficits were reduced in mice treated with synbiotics, suggesting that dietary modulation of the gut–brain axis is a potential approach to delay AD progression. |
doi_str_mv | 10.1002/iub.2589 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2615109397</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2615109397</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3499-80f18709331c51d34f7bff3a9b0de5e17d2e0e099effae5033268a98873510023</originalsourceid><addsrcrecordid>eNp1kclKBDEQhoMozriATyABD3ppTTrTS46juIHgRc8hna5ohixjp1sZL766aTdEMIRUDh9f_VQhtEfJMSUkPzFDc5wXNV9DU1rkNCuLgq7__GdsgrZiXJB0KsI30YTNeJmXnE7R290j4AY8aKOMtBi0BtXjoHFc-caE3qiIVfBxcMveBI_TndvXRzAOusOIWxNBRsAuDB9vCxY_G4k7aAdl_AO2QSWt9G0Sxh6cUdh4baVzcvTtoA0tbYTdr7qN7i_O786uspvby-uz-U2mUlae1UTTOmVnjKqCtmymq0ZrJnlDWiiAVm0OBAjnKb-EgjCWl7XkdV2xYpwQ20ZHn95lF54GiL1wJiqwVnpI0UVe0gRyxquEHvxBF2HofEonxpnVqUv1S6i6EGMHWiw742S3EpSIsaVISxHjUhK6_yUcGgftD_i9hQRkn8CLsbD6VySu708_hO99_ZZ1</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2691809972</pqid></control><display><type>article</type><title>The beneficial effect of synbiotics consumption on Alzheimer's disease mouse model via reducing local and systemic inflammation</title><source>Wiley Online Library Free Content</source><source>Access via Wiley Online Library</source><creator>Deng, Shin‐Meng ; Chen, Chia‐Jung ; Lin, Hung‐Lung ; Cheng, Irene H.</creator><creatorcontrib>Deng, Shin‐Meng ; Chen, Chia‐Jung ; Lin, Hung‐Lung ; Cheng, Irene H.</creatorcontrib><description>Alzheimer's disease (AD) is a neurodegenerative disease that impairs multiple memory domains without an effective prevention or treatment approach. Amyloid plaque‐induced neuroinflammation exacerbates neurodegeneration and cognitive impairment in AD. To reduce neuroinflammation, we applied prebiotics or synbiotics to modulate the gut–brain axis in the AD mouse model. AD‐like deficits were reduced in mice treated with synbiotics, suggesting that dietary modulation of the gut–brain axis is a potential approach to delay AD progression.</description><identifier>ISSN: 1521-6543</identifier><identifier>EISSN: 1521-6551</identifier><identifier>DOI: 10.1002/iub.2589</identifier><identifier>PMID: 34962691</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley & Sons, Inc</publisher><subject>Alzheimer's disease ; Amyloid ; Cognitive ability ; Inflammation ; Neurodegeneration ; Neurodegenerative diseases ; neuroinflammation ; synbiotics</subject><ispartof>IUBMB life, 2022-08, Vol.74 (8), p.748-753</ispartof><rights>2021 International Union of Biochemistry and Molecular Biology</rights><rights>2021 International Union of Biochemistry and Molecular Biology.</rights><rights>2022 International Union of Biochemistry and Molecular Biology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3499-80f18709331c51d34f7bff3a9b0de5e17d2e0e099effae5033268a98873510023</citedby><cites>FETCH-LOGICAL-c3499-80f18709331c51d34f7bff3a9b0de5e17d2e0e099effae5033268a98873510023</cites><orcidid>0000-0002-3737-3877 ; 0000-0002-6739-5452</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fiub.2589$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fiub.2589$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,1433,27924,27925,45574,45575,46409,46833</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34962691$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Deng, Shin‐Meng</creatorcontrib><creatorcontrib>Chen, Chia‐Jung</creatorcontrib><creatorcontrib>Lin, Hung‐Lung</creatorcontrib><creatorcontrib>Cheng, Irene H.</creatorcontrib><title>The beneficial effect of synbiotics consumption on Alzheimer's disease mouse model via reducing local and systemic inflammation</title><title>IUBMB life</title><addtitle>IUBMB Life</addtitle><description>Alzheimer's disease (AD) is a neurodegenerative disease that impairs multiple memory domains without an effective prevention or treatment approach. Amyloid plaque‐induced neuroinflammation exacerbates neurodegeneration and cognitive impairment in AD. To reduce neuroinflammation, we applied prebiotics or synbiotics to modulate the gut–brain axis in the AD mouse model. AD‐like deficits were reduced in mice treated with synbiotics, suggesting that dietary modulation of the gut–brain axis is a potential approach to delay AD progression.</description><subject>Alzheimer's disease</subject><subject>Amyloid</subject><subject>Cognitive ability</subject><subject>Inflammation</subject><subject>Neurodegeneration</subject><subject>Neurodegenerative diseases</subject><subject>neuroinflammation</subject><subject>synbiotics</subject><issn>1521-6543</issn><issn>1521-6551</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp1kclKBDEQhoMozriATyABD3ppTTrTS46juIHgRc8hna5ohixjp1sZL766aTdEMIRUDh9f_VQhtEfJMSUkPzFDc5wXNV9DU1rkNCuLgq7__GdsgrZiXJB0KsI30YTNeJmXnE7R290j4AY8aKOMtBi0BtXjoHFc-caE3qiIVfBxcMveBI_TndvXRzAOusOIWxNBRsAuDB9vCxY_G4k7aAdl_AO2QSWt9G0Sxh6cUdh4baVzcvTtoA0tbYTdr7qN7i_O786uspvby-uz-U2mUlae1UTTOmVnjKqCtmymq0ZrJnlDWiiAVm0OBAjnKb-EgjCWl7XkdV2xYpwQ20ZHn95lF54GiL1wJiqwVnpI0UVe0gRyxquEHvxBF2HofEonxpnVqUv1S6i6EGMHWiw742S3EpSIsaVISxHjUhK6_yUcGgftD_i9hQRkn8CLsbD6VySu708_hO99_ZZ1</recordid><startdate>202208</startdate><enddate>202208</enddate><creator>Deng, Shin‐Meng</creator><creator>Chen, Chia‐Jung</creator><creator>Lin, Hung‐Lung</creator><creator>Cheng, Irene H.</creator><general>John Wiley & Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-3737-3877</orcidid><orcidid>https://orcid.org/0000-0002-6739-5452</orcidid></search><sort><creationdate>202208</creationdate><title>The beneficial effect of synbiotics consumption on Alzheimer's disease mouse model via reducing local and systemic inflammation</title><author>Deng, Shin‐Meng ; Chen, Chia‐Jung ; Lin, Hung‐Lung ; Cheng, Irene H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3499-80f18709331c51d34f7bff3a9b0de5e17d2e0e099effae5033268a98873510023</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Alzheimer's disease</topic><topic>Amyloid</topic><topic>Cognitive ability</topic><topic>Inflammation</topic><topic>Neurodegeneration</topic><topic>Neurodegenerative diseases</topic><topic>neuroinflammation</topic><topic>synbiotics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Deng, Shin‐Meng</creatorcontrib><creatorcontrib>Chen, Chia‐Jung</creatorcontrib><creatorcontrib>Lin, Hung‐Lung</creatorcontrib><creatorcontrib>Cheng, Irene H.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>IUBMB life</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Deng, Shin‐Meng</au><au>Chen, Chia‐Jung</au><au>Lin, Hung‐Lung</au><au>Cheng, Irene H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The beneficial effect of synbiotics consumption on Alzheimer's disease mouse model via reducing local and systemic inflammation</atitle><jtitle>IUBMB life</jtitle><addtitle>IUBMB Life</addtitle><date>2022-08</date><risdate>2022</risdate><volume>74</volume><issue>8</issue><spage>748</spage><epage>753</epage><pages>748-753</pages><issn>1521-6543</issn><eissn>1521-6551</eissn><abstract>Alzheimer's disease (AD) is a neurodegenerative disease that impairs multiple memory domains without an effective prevention or treatment approach. Amyloid plaque‐induced neuroinflammation exacerbates neurodegeneration and cognitive impairment in AD. To reduce neuroinflammation, we applied prebiotics or synbiotics to modulate the gut–brain axis in the AD mouse model. AD‐like deficits were reduced in mice treated with synbiotics, suggesting that dietary modulation of the gut–brain axis is a potential approach to delay AD progression.</abstract><cop>Hoboken, USA</cop><pub>John Wiley & Sons, Inc</pub><pmid>34962691</pmid><doi>10.1002/iub.2589</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-3737-3877</orcidid><orcidid>https://orcid.org/0000-0002-6739-5452</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1521-6543 |
ispartof | IUBMB life, 2022-08, Vol.74 (8), p.748-753 |
issn | 1521-6543 1521-6551 |
language | eng |
recordid | cdi_proquest_miscellaneous_2615109397 |
source | Wiley Online Library Free Content; Access via Wiley Online Library |
subjects | Alzheimer's disease Amyloid Cognitive ability Inflammation Neurodegeneration Neurodegenerative diseases neuroinflammation synbiotics |
title | The beneficial effect of synbiotics consumption on Alzheimer's disease mouse model via reducing local and systemic inflammation |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T02%3A11%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20beneficial%20effect%20of%20synbiotics%20consumption%20on%20Alzheimer's%20disease%20mouse%20model%20via%20reducing%20local%20and%20systemic%20inflammation&rft.jtitle=IUBMB%20life&rft.au=Deng,%20Shin%E2%80%90Meng&rft.date=2022-08&rft.volume=74&rft.issue=8&rft.spage=748&rft.epage=753&rft.pages=748-753&rft.issn=1521-6543&rft.eissn=1521-6551&rft_id=info:doi/10.1002/iub.2589&rft_dat=%3Cproquest_cross%3E2615109397%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2691809972&rft_id=info:pmid/34962691&rfr_iscdi=true |